Volgen
Bonny Parkinson
Titel
Geciteerd door
Geciteerd door
Jaar
Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review
B Parkinson, C Sermet, F Clement, S Crausaz, B Godman, S Garner, ...
Pharmacoeconomics 33, 905-924, 2015
1042015
Financial cost of lymphedema borne by women with breast cancer
J Boyages, Y Xu, S Kalfa, L Koelmeyer, B Parkinson, H Mackie, H Viveros, ...
Psycho‐Oncology 26 (6), 849-855, 2017
1022017
Cost‐effectiveness of lumbar artificial intervertebral disc replacement: driven by the choice of comparator
B Parkinson, S Goodall, P Thavaneswaran
ANZ Journal of Surgery 83 (9), 669-675, 2013
522013
Integrating health economics into the product development cycle: a case study of absorbable pins for treating hallux valgus
L Vallejo-Torres, L Steuten, B Parkinson, AJ Girling, MJ Buxton
Medical Decision Making 31 (4), 596-610, 2011
512011
Economic evaluations of childhood hearing loss screening programmes: a systematic review and critique
R Sharma, Y Gu, TYC Ching, V Marnane, B Parkinson
Applied health economics and health policy 17, 331-357, 2019
272019
The cost-effectiveness of mandatory folic acid fortification in Australia
V Rabovskaja, B Parkinson, S Goodall
The Journal of nutrition 143 (1), 59-66, 2013
252013
Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique
B Parkinson, SA Pearson, R Viney
The European Journal of Health Economics 15, 93-112, 2014
232014
Cost‐effectiveness of the BRECONDA decision aid for women with breast cancer: Results from a randomized controlled trial
B Parkinson, KA Sherman, P Brown, LKE Shaw, J Boyages, LD Cameron, ...
Psycho‐Oncology 27 (6), 1589-1596, 2018
192018
Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol
A Morrow, E Hogden, YJ Kang, J Steinberg, K Canfell, MJ Solomon, ...
Trials 20, 1-12, 2019
162019
Long‐term health care costs for patients with prostate cancer: a population‐wide longitudinal study in New South Wales, Australia
P Cronin, B Kirkbride, A Bang, B Parkinson, D Smith, P Haywood
Asia‐Pacific Journal of Clinical Oncology 13 (3), 160-171, 2017
162017
Resource use, costs and quality of end-of-life care: observations in a cohort of elderly Australian cancer decedents
JM Langton, P Srasuebkul, R Reeve, B Parkinson, Y Gu, NA Buckley, ...
Implementation Science 10, 1-14, 2015
162015
The cost-effectiveness of unilateral cochlear implants in UK adults
H Cutler, M Gumbie, E Olin, B Parkinson, R Bowman, H Quadri, T Mann
The European Journal of Health Economics, 1-17, 2022
152022
Cost-effectiveness of cardiovascular magnetic resonance in diagnosing coronary artery disease in the Australian Health Care System
R Kozor, S Walker, B Parkinson, J Younger, C Hamilton-Craig, ...
Heart, Lung and Circulation 30 (3), 380-387, 2021
152021
Cost-effectiveness analysis of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) for the primary staging of prostate cancer in …
R Song, V Jeet, R Sharma, M Hoyle, B Parkinson
Pharmacoeconomics 40 (8), 807-821, 2022
132022
Real-world evidence: a comparison of The Australian Herceptin Program and clinical trials of trastuzumab for HER2-positive metastatic breast cancer
B Parkinson, R Viney, M Haas, S Goodall, P Srasuebkul, SA Pearson
Pharmacoeconomics 34, 1039-1050, 2016
132016
The cost-effectiveness of Cochlear implants in Swedish adults
M Gumbie, E Olin, B Parkinson, R Bowman, H Cutler
BMC health services research 21, 1-14, 2021
112021
Considering consumer choice in the economic evaluation of mandatory health programmes: A review
B Parkinson, S Goodall
Health policy 101 (3), 236-244, 2011
112011
Medicare Australia data for research: an introduction
K Van Gool, B Parkinson, P Kenny
CREST Factsheet, 2011
102011
The real-world cost-effectiveness of coronary artery bypass surgery versus stenting in high-risk patients: propensity score-matched analysis of a single-centre experience
TV Ariyaratne, Z Ademi, M Huq, F Rosenfeldt, SJ Duffy, B Parkinson, ...
Applied Health Economics and Health Policy 16 (5), 661-674, 2018
92018
Histopathologically validated diagnostic accuracy of PSMA-PET/CT in the primary and secondary staging of prostate cancer and the impact of PSMA-PET/CT on clinical management: a …
V Jeet, B Parkinson, R Song, R Sharma, M Hoyle
Seminars in Nuclear Medicine, 2023
82023
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20